---
trial_id: 305
discovery_date: 2022-04-02 17:30:15.320378
date: 2022-04-02 17:30:15.320378
title: "A Study for Tysabri Participant Preference"
summary: |
  <b>Condition</b>:    Relapsing-Remitting Multiple Sclerosis (RRMS)<br /><b>Intervention</b>:    Drug: Natalizumab<br /><b>Sponsor</b>:    Biogen<br /><b>Recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05304520?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-03-31 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Relapsing-Remitting Multiple Sclerosis (RRMS)<br /><b>Intervention</b>:    Drug: Natalizumab<br /><b>Sponsor</b>:    Biogen<br /><b>Recruiting</b>